Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy

Related Experiment Video

Updated: Jul 1, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K

Man Wang1, Fei Yu1, Yuan Zhang1

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China.

Frontiers in Immunology
|March 6, 2024
PubMed

Insights

The Notch signaling pathway influences cancer immunity by modulating the tumor microenvironment. Targeting Notch signaling offers potential for improving cancer immunotherapy efficacy.

Area of Science:

  • Cellular biology
  • Immunology
  • Oncology

Background:

  • The Notch signaling pathway is crucial for cell communication in development and homeostasis.
  • Dysregulated Notch signaling is implicated in cancer, affecting cancer stem cells, metabolism, angiogenesis, and tumor immunity.
  • Notch signaling impacts immune cells within the tumor microenvironment (TME), influencing anti-tumor and pro-tumor responses.

Purpose of the Study:

  • To review the role of the Notch signaling pathway in remodeling the tumor immune microenvironment.
  • To analyze the impact of Notch signaling on cancer immunotherapy efficacy.
  • To summarize preclinical and clinical trial results of Notch-targeted therapeutics.

Main Methods:

  • Literature review focusing on Notch signaling in cancer immunity.
  • Analysis of Notch pathway's influence on tumor immune cells and immunotherapy response.
  • Compilation of data from preclinical and clinical trials of Notch-targeted therapies.

Main Results:

  • Notch signaling significantly impacts immune cell populations and functions within the TME.
  • Modulation of Notch signaling can alter the efficacy of existing cancer immunotherapies.
  • Notch-targeted therapeutics show promise but face challenges in clinical application.

Conclusions:

  • Understanding Notch signaling's role in tumor immunity is key to developing novel cancer immunotherapies.
  • Targeting the Notch pathway may enhance anti-tumor immunity and improve treatment outcomes.
  • Further research and clinical trials are needed to overcome challenges in Notch-targeted cancer therapy.
Keywords:
Notch signalingNotch-targeted therapeuticscancer developmentcancer immunotherapytumor immunitytumor microenvironment

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

335
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K